Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge
Opsoclonus-myoclonus syndrome (OMS) is a neurological non-fatal disease that usually responds to immunotherapies. However, the real challenge is to counteract the high frequency of relapses and long-term developmental sequelae. Since the OMS is extremely rare, a common consensus regarding therapeuti...
Main Authors: | Marina Auconi, Laura Papetti, Claudia Ruscitto, Michela Ada Noris Ferilli, Fabiana Ursitti, Giorgia Sforza, Federico Vigevano, Massimiliano Valeriani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/8/11/965 |
Similar Items
-
The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours—Single-Centre Experience and Literature Review
by: Agnieszka Mizia-Malarz, et al.
Published: (2020-08-01) -
Hyperammonemia presenting as opsoclonus–myoclonus–ataxia–tremor syndrome: A case report
by: Sandhya Manorenj, et al.
Published: (2022-01-01) -
Opsoclonus-myoclonus-ataxia syndrome presenting in Enugu, Southeast Nigeria: A case report
by: Adaobi Ikemeh, et al.
Published: (2019-01-01) -
Evolving Cognitive Dysfunction in Children with Neurologically Stable Opsoclonus–Myoclonus Syndrome
by: En Lin Goh, et al.
Published: (2020-08-01) -
Recommendations for Neuroblastoma Associated Opsoclonus-myoclonus-ataxia Syndrome in Childhood
by: Chinese Research Hospital Association- Children's Oncology Committee, et al.
Published: (2022-07-01)